Insider Transactions in Q3 2022 at Molina Healthcare, Inc. (MOH)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.38%
|
$10,020,000
$334.06 P/Share
|
|
Sep 30
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 29
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-3.6%
|
$9,930,000
$331.76 P/Share
|
|
Sep 29
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 28
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.83%
|
$9,960,000
$332.98 P/Share
|
|
Sep 28
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 27
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
18,210
-1.69%
|
$6,027,510
$331.9 P/Share
|
|
Sep 27
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,210
+6.25%
|
$1,220,070
$67.33 P/Share
|
|
Sep 22
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-3.61%
|
$9,930,000
$331.39 P/Share
|
|
Sep 22
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 21
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
27,276
-1.12%
|
$9,164,736
$336.18 P/Share
|
|
Sep 21
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,876
+8.97%
|
$1,867,692
$67.33 P/Share
|
|
Sep 20
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.56%
|
$10,170,000
$339.28 P/Share
|
|
Sep 20
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 19
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,600
-1.12%
|
$10,373,400
$339.73 P/Share
|
|
Sep 19
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 15
2022
|
Richard M Schapiro Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
300
-1.98%
|
$103,200
$344.19 P/Share
|
|
Sep 09
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
150
-0.9%
|
$53,100
$354.29 P/Share
|
|
Sep 08
2022
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
14,480
-17.96%
|
$5,068,000
$350.0 P/Share
|
|
Sep 08
2022
|
Daniel Cooperman Director |
SELL
Open market or private sale
|
Direct |
2,500
-35.16%
|
$882,500
$353.0 P/Share
|
|
Sep 08
2022
|
Daniel Cooperman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+26.01%
|
$82,500
$33.02 P/Share
|
|
Sep 07
2022
|
Daniel Cooperman Director |
SELL
Open market or private sale
|
Direct |
2,500
-35.16%
|
$865,000
$346.0 P/Share
|
|
Sep 07
2022
|
Daniel Cooperman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+26.01%
|
$82,500
$33.02 P/Share
|
|
Aug 26
2022
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
500
-2.41%
|
$177,500
$355.4 P/Share
|
|
Aug 12
2022
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
536
-0.66%
|
$178,488
$333.02 P/Share
|
|
Aug 09
2022
|
Mark Lowell Keim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,000
-13.66%
|
$3,960,000
$330.24 P/Share
|
|
Aug 09
2022
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
90
-0.11%
|
$29,970
$333.01 P/Share
|
|
Aug 08
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
200
-1.19%
|
$65,400
$327.04 P/Share
|
|
Aug 03
2022
|
James Woys Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-39.8%
|
$8,200,000
$328.11 P/Share
|
|
Aug 02
2022
|
Dale B Wolf Director |
SELL
Open market or private sale
|
Direct |
2,000
-14.47%
|
$654,000
$327.99 P/Share
|
|
Aug 02
2022
|
Dale B Wolf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+12.64%
|
$66,000
$33.02 P/Share
|
|
Jul 01
2022
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
194
+1.14%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+4.62%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+1.26%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
194
+0.93%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+1.61%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+15.29%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
194
+3.54%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+4.04%
|
$54,708
$282.9 P/Share
|